Breast cancer screening, diagnostic accuracy and health care policies.
作者信息
Urbain Jean-Luc
机构信息
Department of Nuclear Medicine, St. Joseph's Health Centre, London, Ont.
出版信息
CMAJ. 2005 Jan 18;172(2):210-1. doi: 10.1503/cmaj.1041498.
Abstract
摘要
相似文献
1
Breast cancer screening, diagnostic accuracy and health care policies.乳腺癌筛查、诊断准确性与医疗保健政策。
CMAJ. 2005 Jan 18;172(2):210-1. doi: 10.1503/cmaj.1041498.
2
Volume of screening mammography and performance in the Quebec population-based Breast Cancer Screening Program.魁北克基于人群的乳腺癌筛查项目中乳腺钼靶筛查量及效果
CMAJ. 2005 Jan 18;172(2):195-9. doi: 10.1503/cmaj.1040485.
3
Physician predictors of mammographic accuracy.乳腺钼靶检查准确性的医生预测因素。
J Natl Cancer Inst. 2005 Mar 2;97(5):358-67. doi: 10.1093/jnci/dji060.
4
Measuring the performance of screening mammography in community practice with Medicare claims data.利用医疗保险理赔数据评估社区实践中乳腺钼靶筛查的效果。
Women Health. 2003;37(2):1-15. doi: 10.1300/J013v37n02_01.
5
Mammography in 53,803 women from the New Hampshire mammography network.来自新罕布什尔州乳腺X线摄影网络的53803名女性的乳腺X线摄影检查。
Radiology. 2000 Dec;217(3):832-40. doi: 10.1148/radiology.217.3.r00dc33832.
6
Should women 40 to 49 years of age be offered mammographic screening?40至49岁的女性应该接受乳房X光筛查吗？
Can Fam Physician. 2006 Sep;52(9):1050-2.
7
[Mammography screening in the county of Copenhagen. Results of the first three screening rounds].[哥本哈根县的乳腺X线筛查。前三轮筛查结果]
Ugeskr Laeger. 2002 Feb 18;164(8):1048-52.
8
Influence of hormone replacement therapy on the accuracy of screening mammography.激素替代疗法对乳腺钼靶筛查准确性的影响。
Breast J. 2006 Mar-Apr;12(2):154-8. doi: 10.1111/j.1075-122X.2006.00224.x.
9
Canadian National Breast Screening Study: response.加拿大全国乳腺筛查研究：回应
CMAJ. 1993 Nov 15;149(10):1374-5.
10
Breast screening in women aged 40-49 years: what next?40至49岁女性的乳房筛查：下一步该怎么做？
Lancet. 1999 Jun 5;353(9168):1896-7. doi: 10.1016/S0140-6736(99)90074-0.
引用本文的文献
1
Seven-year overall survival of trastuzumabe versus alternative systemic therapies in a Brazilian breast cancer cohort.在巴西乳腺癌队列中，曲妥珠单抗与其他全身治疗方法的7年总生存率。
Sci Rep. 2025 Feb 12;15(1):5296. doi: 10.1038/s41598-025-88575-3.
2
Quantitative STAU2 measurement in lymphocytes for breast cancer risk assessment.定量检测淋巴细胞中 STAU2 水平用于乳腺癌风险评估。
Sci Rep. 2021 Jan 13;11(1):915. doi: 10.1038/s41598-020-79622-2.
3
Preliminary in vivo breast vibro-acoustography results with a quasi-2-d array transducer: a step forward.使用准二维阵列换能器的乳腺振动声学造影初步体内研究结果：向前迈进的一步。
Ultrasound Med Biol. 2014 Dec;40(12):2819-29. doi: 10.1016/j.ultrasmedbio.2014.07.005.
4
Breast imaging: how we manage diagnostic technology at a multidisciplinary breast center.乳腺影像学：多学科乳腺中心如何管理诊断技术。
J Oncol. 2012;2012:213421. doi: 10.1155/2012/213421. Epub 2012 Jul 5.
本文引用的文献
1
Volume of screening mammography and performance in the Quebec population-based Breast Cancer Screening Program.魁北克基于人群的乳腺癌筛查项目中乳腺钼靶筛查量及效果
CMAJ. 2005 Jan 18;172(2):195-9. doi: 10.1503/cmaj.1040485.
2
Performance and reporting of clinical breast examination: a review of the literature.临床乳腺检查的操作与报告：文献综述
CA Cancer J Clin. 2004 Nov-Dec;54(6):345-61. doi: 10.3322/canjclin.54.6.345.
3
Potential economic effects of volume-outcome relationships in the treatment of three common cancers.三种常见癌症治疗中量-效关系的潜在经济影响。
Cancer Control. 2004 Jul-Aug;11(4):258-64. doi: 10.1177/107327480401100409.
4
Association of volume and volume-independent factors with accuracy in screening mammogram interpretation.乳房X线筛查影像解读中容积及非容积因素与准确性的关联
J Natl Cancer Inst. 2003 Feb 19;95(4):282-90. doi: 10.1093/jnci/95.4.282.
5
Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations.乳腺钼靶筛查、体格检查和乳腺超声检查的性能比较及影响因素评估：对27825例患者评估的分析
Radiology. 2002 Oct;225(1):165-75. doi: 10.1148/radiol.2251011667.
6
The impact of alternative practices on the cost and quality of mammographic screening in the United States.替代做法对美国乳腺钼靶筛查成本和质量的影响。
Clin Breast Cancer. 2001 Jul;2(2):145-52. doi: 10.3816/CBC.2001.n.019.
7
Improving the accuracy of mammography: volume and outcome relationships.提高乳腺钼靶检查的准确性：体积与结果的关系
J Natl Cancer Inst. 2002 Mar 6;94(5):369-75. doi: 10.1093/jnci/94.5.369.
8
Standardized abnormal interpretation and cancer detection ratios to assess reading volume and reader performance in a breast screening program.标准化异常解读及癌症检出率，以评估乳腺筛查项目中的阅读量及阅片者表现。
Radiology. 2000 May;215(2):563-7. doi: 10.1148/radiology.215.2.r00ma42563.
9
Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers.乳腺肿瘤特征作为乳腺钼靶检测的预测指标：间期癌与筛查发现癌的比较
J Natl Cancer Inst. 1999 Dec 1;91(23):2020-8. doi: 10.1093/jnci/91.23.2020.
10
Variability and accuracy in mammographic interpretation using the American College of Radiology Breast Imaging Reporting and Data System.使用美国放射学会乳腺影像报告和数据系统进行乳腺钼靶影像解读的变异性与准确性。
J Natl Cancer Inst. 1998 Dec 2;90(23):1801-9. doi: 10.1093/jnci/90.23.1801.
Zotero 插件